Skip to main content

Table 1 Study characteristics of all included RCTs

From: Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis

 

Study

Study location

Study date

Population

Procedure

Control medication

Total number of patients

Mean age (years)

Male (%)

Delirium assessment

Endpoint delirium

Sedation comparison

Chang [52]

Taiwan

2014–2015

Non-cardiac surgery

Postoperatively for a maximum of 24 h, RASS-2-0

Propofol

60

70.5

58.3

CAM-ICU

2

Lee [55]

South Korea

2016–2017

Non-cardiac surgery

Intraoperatively as continuous infusion or bolus

Placebo

318

73

44.3

CAM

1

Mei [54]

China

2016–2017

Non-cardiac surgery

Intraoperatively as bolus and subsequent continuous infusion

Propofol

296

75

45.6

CAM

1

Sheikh [53]

India

2014–2016

Cardiac surgery

Intraoperatively as bolus and subsequent continuous infusion

Propofol

60

34.6

N/A

*

2

Skrobik [56]

USA

2013–2016

MV**

9:30 in the evening until 6:15 the next morning, continuous infusion without bolus, RASS-1

Placebo

100

62.3

64

ICDSC

1

Deiner [33]

USA

2008–2014

Non-cardiac surgery

Entering OR until 2 h in recovery room

Placebo

390

74***

48.7

CAM CAM-ICU

1

Kawazoe [44]

Japan

2013–2016

MV

Continuously until end of MV, RASS-0 by day, RASS-2 by night

Propofol midazolam

201

68.5

63.2

CAM

2

Li [45]

China

2014–2015

Cardiac surgery

Intraoperatively and continuously until end of MV

Placebo

285

67

69.1

CAM CAM-ICU

1

Li [43]

China

2015–2016

MV

Sedation for at least 48 h until end of MV, RASS-0–1 in intervention, RASS − 2/− 3 in control group

Propofol, midazolam

126

44

56.3

CAM-ICU

1

Djaiani [46]

Canada

2011–2014

Cardiac surgery

Postoperatively and continuously until end of MV

Propofol

183

72.6

75.4

CAM CAM-ICU

1

Liu [47]

China

2015

Cardiac surgery

Postoperatively on ICU admission and continuously until end of MV, RASS-3-0

Propofol

61

54***

41

CAM

2

Liu [49]

China

2014–2016

Non-cardiac surgery

Intraoperatively until 20 min before end of surgery

Placebo

197

73

48.7

CAM

1

Su [58]

China

2011–2013

Non-cardiac surgery

Postoperatively until 8:00 the next morning

Placebo

700

74.4

60.4

CAM

1

MacLaren [50]

USA

2009–2012

MV

Continuously until end of MV, according to desired SAS

Midazolam

23

58.1

56.5

ICDSC

2

Priye [51]

India

2012–2013

Cardiac surgery

Postoperatively for 12 h

Placebo

64

43.3

51.6

RASS

2

Yang [34]

China

2013

Non-cardiac surgery

Intraoperatively until 1 h before end of surgery and postoperatively until 6:00 the next morning

Placebo

79

50.5

53.2

CAM-ICU

2

Devlin [35]

USA

2008–2012

NIV

2 h stable after NIV mask removal, SAS 3–4

Placebo

33

65

51.5

ICDSC

2

Park [36]

South Korea

2012–2013

Cardiac surgery

Postoperatively until end of MV, RSS 2–3

Remifentanil

142

52.7

55.6

CAM-ICU

1

Huang [37]

China

2008–2011

NIV

Until end of sedation, RSS 2–3

Midazolam

62

64.5

41.9

N/A

2

Jakob [38]

Europe + Russia

2007–2010

MV

Continuously until end of MV, RASS-3-0

Propofol, midazolam

998

65***

65.5

CAM-ICU

2

Maldonado [39]

USA

N/A

Cardiac surgery

Postoperatively until end of MV

Propofol, midazolam

118

57.7

63.6

CAM CAM-ICU

1

Ruokonen [40]

Switzerland + Finland

N/A

MV

Continuously until end of MV, according to desired RASS

Propofol, midazolam

85

66***

82.4

CAM-ICU

2

Shehabi [41]

Australia

2004–2007

Cardiac surgery

Postoperatively until ICU discharge, MAAS 2–4

Morphine

299

71.3***

75.3

CAM-ICU

1

Pandharipande [32]

USA

2004–2006

MV

Continuously until end of MV, according to desired RASS

Lorazepam

103

59.5***

51.5

CAM-ICU

1

Corbett [42]

USA

2002–2004

Cardiac surgery

Postoperatively until end of MV, RSS 5 the first 2 h, RSS 3–4 afterward

Propofol

89

63

82

N/A

3

Treatment comparison

Reade [57]

Australia + New Zealand

2011–2013

AD (MV)

According to desired RASS = 0

Placebo

74

57.3***

75.7

CAM-ICU

3

Yapici 2010

Turkey

2005–2007

AD (cardiac surgery)

According to blood pressure and heart rate

Midazolam

72

60

37.5

CAM-ICU

3

Reade [59]

Australia

2006–2008

AD (MV)

According to desired RASS = 0

Haloperidol

20

60.3***

85

ICDSC

3

  1. Incidence comparison, normal matter; treatment comparison, italic matter
  2. AD agitated delirium, CAM confusion assessment method, CAM-ICU confusion assessment method for intensive care unit, h hours, ICDSC intensive care delirium screening checklist, MAAS Motor Activity Assessment Scale, MV mechanical ventilation, N/A not available, NIV noninvasive ventilation, OR operating room, RASS Richmond Agitation and Sedation Scale, RSS Ramsay Sedation Scale, SAS Riker Sedation and Agitation Scale
  3. 1, primary endpoint; 2, secondary endpoint; 3, no specific endpoint
  4. *Delirium defined as shourt course illusions, confusion, and cerebral excitement in the postoperative period; **Most; ***Median age